BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
16:45
/
50%
€62.64
Target price
04.10.25
€78.35
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 04.10.25. The prediction end date can be changed by Barclays_PLC at any time.Performance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | - |
iShares Core DAX® | -1.471% |
iShares Nasdaq 100 | -0.486% |
iShares Nikkei 225® | -2.115% |
iShares S&P 500 | 0.394% |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Barclays PLC from $110.00 to $86.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.46
06.08.24
06.08.24
€100.74
06.08.25
06.08.25
-21.17%
16:23
16:23